Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07685730 · ClinicalTrials.gov registry record
Upper vs Lower Extremity BP in Spinal Cesarean Using ClearSight
A clinical trial, sponsored by Ohio State University.
- Recruiting
- Registry status
- 327
- Enrollment target
NCT07685730: Recruiting study, sponsored by Ohio State University.
NCT07685730 is a clinical trial that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 327 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07685730 is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- 327 participants
- Enrollment target
Study Summary
This is a single-center, prospective observational study in patients undergoing cesarean delivery under spinal or combined spinal-epidural anesthesia. It compares whether continuous noninvasive hemodynamic measurements from the lower extremity (toe) better predict neonatal outcomes than upper extremity (arm/finger) measurements during spinal-induced hypotension. Participants receive standard spinal anesthesia and routine blood pressure management, with additional monitoring using the ClearSight™ system at both upper and lower extremities from before spinal anesthesia through delivery. The primary outcome is a composite of neonatal outcomes (APGAR scores, need for respiratory support, cord gases, and NICU admission). Secondary outcomes include maternal side effects and comfort. Overall, the study evaluates whether lower-extremity hemodynamic monitoring improves detection of clinically relevant hypotension and prediction of neonatal outcomes compared to traditional arm measurements.
Primary Outcome
FAAAN is a composite neonatal outcome measure used in this study to capture clinically relevant indicators of neonatal well-being and immediate post-delivery support needs. It includes abnormal fetal heart rate patterns, Apgar scores at 1 and 5 minutes, requirement for fetal airway support (mask ventilation, supplemental oxygen, CPAP, or intubation), and NICU admission. The primary outcome is the incidence of a composite of poor neonatal outcomes, referred to as FAAAN. This composite includes ab
Interventions
- DEVICE ClearSight
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 327 participants |
| Start Date | 2025-02-06 |
| Est. Completion | 2029-08-06 |
What NCT07685730 shows while recruiting
NCT07685730 is an observational study that tracks outcomes without assigning an intervention. The registered 327 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which ClearSight is the first listed.
NCT07685730 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07685730 about?
NCT07685730 is a clinical study titled "Upper vs Lower Extremity BP in Spinal Cesarean Using ClearSight". This is a single-center, prospective observational study in patients undergoing cesarean delivery under spinal or combined spinal-epidural anesthesia. It compares whether continuous noninvasive hemodynamic measurements from the lower extremity (toe) better predict neonatal outcomes than upper extrem...
What is the current status of trial NCT07685730?
This trial is currently recruiting. The enrollment target is 327 participants. The study started on 2025-02-06. Estimated completion is 2029-08-06.
What interventions are being tested in trial NCT07685730?
The interventions under investigation include: ClearSight (DEVICE).
Who is sponsoring clinical trial NCT07685730?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486378 · 327 participants · Phase 2
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
- NCT06370182 · 327 participants · NA
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
- NCT05156983 · 328 participants · Phase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
- NCT05380401 · 328 participants · NA
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI